Health.Zone Web Search

Search results

1. Results from the Health.Zone Content Network

2. FDA Approves Eversense 6-Month Sensor for People with Diabetes

   www.healthline.com/diabetesmine/eversense-e3-six...

   After a long wait, on Feb. 11, 2022, the company announced Food and Drug Administration (FDA) approval of its Eversense E3 version that can stay in the body for a full 6 months — rather than ...

3. New Diabetes Technology Coming in 2022 - Healthline

   www.healthline.com/diabetesmine/new-diabetes...

   FDA Approves Eversense 6-Month Implantable Glucose Sensor: What People with Diabetes Need to Know The exciting first-ever implantable continuous glucose monitor (CGM) Eversense can now be worn for ...

4. ‘Noninvasive’ Glucose Monitoring for Diabetes: Where Is It Now?

   www.healthline.com/diabetesmine/non-invasive...

   FDA Approves Eversense 6-Month Implantable Glucose Sensor: What People with Diabetes Need to Know The exciting first-ever implantable continuous glucose monitor (CGM) Eversense can now be worn for ...

5. FDA Approves Adult Diabetes Drug for Children - WebMD

   www.webmd.com/diabetes/news/20230621/fda...

   FDA Approves Adult Diabetes Drug for Children. June 21, 2023 – The FDA has approved the drugs Jardiance and Synjardy to be taken by children ages 10 and older who have type 2 diabetes. Type 2 ...

6. Pre-Ozempic Obesity Drugs: Effective and Budget-Friendly - WebMD

   www.webmd.com/obesity/news/20240426/pre-ozempic...

   And two cost-friendly and effective drugs offer lower degrees of weight loss: Contrave (around 9%) and Xenical (5% to 6%). Some patients can get drugmaker coupons for Qsymia and Contrave for as ...

7. FDA approves new version of diabetes drug Mounjaro for ... - AOL

   www.aol.com/news/fda-approves-version-diabetes...

   JONEL ALECCIA. November 8, 2023 at 3:47 PM. A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug ...